FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2083365326> ?p ?o ?g. }

• W2083365326 endingPage "1577" @default.
• W2083365326 startingPage "1567" @default.
• W2083365326 abstract "Dopamine (DA) and the dopaminergic agonists bromocriptine and apomorphine inhibit the secretion of TSH as well as that of PRL by rat anterior pituitary (AP) cells in monolayer culture. The order of potency of the drugs is the same for the inhibition of both hormones: bromocriptine ED50 = 0.006 nM against PRL and 0.017 nM against TSH; apomorphine ED50 = 2.9 and 4.8 nM, respectively, and DA, ED50 = 30 and 370 nM, respectively. The dopaminergic antagonists domperidone (DOM) and metoclopramide prevent the inhibition of TSH and PRL by 10(-6) M DA (IC50 = 0.012 and 0.32 nM for metoclopramide against PRL and TSH, respectively; similarly, IC50 = 0.01 and 0.61 nM for DOM). The action of butaclamol is shown to be stereospecific, in that the (+) isomer is 1000-fold more potent in reversing the inhibition of both TSH and PRL by 10(-6) M DA than the (-) isomer [IC50 = 1.1 and 7200 nM for the (+) and (-) isomers against PRL; similarly, 6.3 and 2600 nM against TSH]. The use of radioligand-binding techniques with tritiated DOM ([3H]DOM) and dihydroergocriptine ([3H]DHE) has demonstrated a high affinity dopaminergic binding site upon rat AP cells under the same conditions as the cell cultures used in the hormone secretion studies. Both ligands have been shown to label a site with high affinity (Kd = 1-2 nM) and low capacity (2-3 fmol/10(5) cells). At this site, dopaminergic agonists and antagonists compete with both radioligands and display a rank order of potency which is the same as that shown against TSH and PRL secretion and which is typically dopaminergic. For [3H]DHE: bromocriptine Ki (0.04 nM) greater than metoclopramide = DOM (0.07 nM) greater than (+)butaclamol (0.7 nM) greater than apomorphine (20 nM) greater than DA (700 nM) greater than (-)butaclamol (2000 nM). Similar data were derived using [3H]DOM. The high affinity site is saturable, has rapid association and dissociation rates, as determined for both radioligands used, and is temperature dependent. In contrast, both radioligands bind to a second binding site on the cells that is of lower affinity (Kd = 244 nM for [3H]DOM and 678 nM for [3H]DHE) and larger capacity (100 fmol/10(5) cells for both ligands). This second site is neither stereospecific nor, using the methodology presented here, does it discriminate between other dopaminergic compounds. It is thus not considered to represent specific DA receptor binding. It is concluded that the dopaminergic stimulus causing the inhibition of TSH and PRL secretion from rat AP cells in culture is mediated via a high affinity DA receptor present upon lactotrophs and thyrotrophs and that this receptor has similar characteristics on the two cell types." @default.
• W2083365326 created "2016-06-24" @default.
• W2083365326 creator A5008355893 @default.
• W2083365326 creator A5044168126 @default.
• W2083365326 creator A5049613488 @default.
• W2083365326 creator A5050453902 @default.
• W2083365326 creator A5081537784 @default.
• W2083365326 date "1983-05-01" @default.
• W2083365326 modified "2023-10-03" @default.
• W2083365326 title "Dopamine Receptors on Intact Anterior Pituitary Cells in Culture: Functional Association with the Inhibition of Prolactin and Thyrotropin*" @default.
• W2083365326 cites W1502799818 @default.
• W2083365326 cites W1519748854 @default.
• W2083365326 cites W1573818845 @default.
• W2083365326 cites W1964627173 @default.
• W2083365326 cites W1965230452 @default.
• W2083365326 cites W1978980888 @default.
• W2083365326 cites W1982514864 @default.
• W2083365326 cites W1985798149 @default.
• W2083365326 cites W1990880840 @default.
• W2083365326 cites W1992832744 @default.
• W2083365326 cites W1994946404 @default.
• W2083365326 cites W1997471873 @default.
• W2083365326 cites W2002278970 @default.
• W2083365326 cites W2011096544 @default.
• W2083365326 cites W2017077592 @default.
• W2083365326 cites W2040834537 @default.
• W2083365326 cites W2043934589 @default.
• W2083365326 cites W2047171463 @default.
• W2083365326 cites W2071870771 @default.
• W2083365326 cites W2079795488 @default.
• W2083365326 cites W2080700416 @default.
• W2083365326 cites W2080858829 @default.
• W2083365326 cites W2083251894 @default.
• W2083365326 cites W2087751874 @default.
• W2083365326 cites W2089083424 @default.
• W2083365326 cites W2098436527 @default.
• W2083365326 cites W2135981692 @default.
• W2083365326 cites W2175087497 @default.
• W2083365326 cites W2202263696 @default.
• W2083365326 doi "https://doi.org/10.1210/endo-112-5-1567" @default.
• W2083365326 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/6832061" @default.
• W2083365326 hasPublicationYear "1983" @default.
• W2083365326 type Work @default.
• W2083365326 sameAs 2083365326 @default.
• W2083365326 citedByCount "94" @default.
• W2083365326 countsByYear W20833653262012 @default.
• W2083365326 countsByYear W20833653262013 @default.
• W2083365326 countsByYear W20833653262014 @default.
• W2083365326 countsByYear W20833653262015 @default.
• W2083365326 countsByYear W20833653262016 @default.
• W2083365326 countsByYear W20833653262017 @default.
• W2083365326 countsByYear W20833653262018 @default.
• W2083365326 countsByYear W20833653262023 @default.
• W2083365326 crossrefType "journal-article" @default.
• W2083365326 hasAuthorship W2083365326A5008355893 @default.
• W2083365326 hasAuthorship W2083365326A5044168126 @default.
• W2083365326 hasAuthorship W2083365326A5049613488 @default.
• W2083365326 hasAuthorship W2083365326A5050453902 @default.
• W2083365326 hasAuthorship W2083365326A5081537784 @default.
• W2083365326 hasConcept C120069818 @default.
• W2083365326 hasConcept C126322002 @default.
• W2083365326 hasConcept C134018914 @default.
• W2083365326 hasConcept C137183658 @default.
• W2083365326 hasConcept C170493617 @default.
• W2083365326 hasConcept C185592680 @default.
• W2083365326 hasConcept C2776856834 @default.
• W2083365326 hasConcept C2777525119 @default.
• W2083365326 hasConcept C2778479196 @default.
• W2083365326 hasConcept C2779029589 @default.
• W2083365326 hasConcept C2779064019 @default.
• W2083365326 hasConcept C2780852908 @default.
• W2083365326 hasConcept C42533223 @default.
• W2083365326 hasConcept C513476851 @default.
• W2083365326 hasConcept C54799321 @default.
• W2083365326 hasConcept C71315377 @default.
• W2083365326 hasConcept C71924100 @default.
• W2083365326 hasConcept C86803240 @default.
• W2083365326 hasConcept C98274493 @default.
• W2083365326 hasConceptScore W2083365326C120069818 @default.
• W2083365326 hasConceptScore W2083365326C126322002 @default.
• W2083365326 hasConceptScore W2083365326C134018914 @default.
• W2083365326 hasConceptScore W2083365326C137183658 @default.
• W2083365326 hasConceptScore W2083365326C170493617 @default.
• W2083365326 hasConceptScore W2083365326C185592680 @default.
• W2083365326 hasConceptScore W2083365326C2776856834 @default.
• W2083365326 hasConceptScore W2083365326C2777525119 @default.
• W2083365326 hasConceptScore W2083365326C2778479196 @default.
• W2083365326 hasConceptScore W2083365326C2779029589 @default.
• W2083365326 hasConceptScore W2083365326C2779064019 @default.
• W2083365326 hasConceptScore W2083365326C2780852908 @default.
• W2083365326 hasConceptScore W2083365326C42533223 @default.
• W2083365326 hasConceptScore W2083365326C513476851 @default.
• W2083365326 hasConceptScore W2083365326C54799321 @default.
• W2083365326 hasConceptScore W2083365326C71315377 @default.
• W2083365326 hasConceptScore W2083365326C71924100 @default.
• W2083365326 hasConceptScore W2083365326C86803240 @default.
• W2083365326 hasConceptScore W2083365326C98274493 @default.
• W2083365326 hasIssue "5" @default.

• next